Your browser doesn't support javascript.
loading
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial.
Gupta, Samir K; Berhe, Mezgebe; Crofoot, Gordon; Benson, Paul; Ramgopal, Moti; Sims, James; McDonald, Cheryl; Ruane, Peter; Sanchez, William E; Scribner, Anita; Liu, Shan-Yu; VanderVeen, Laurie A; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared M; Koenig, Ellen.
Afiliação
  • Gupta SK; Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: sgupta1@iu.edu.
  • Berhe M; North Texas Infectious Diseases Consultants, Dallas, TX, USA.
  • Crofoot G; The Crofoot Research Center, Houston, TX, USA.
  • Benson P; Be Well Medical Center, Berkley, MI, USA.
  • Ramgopal M; Midway Immunology & Research Center, Fort Pierce, FL, USA.
  • Sims J; St Hope Foundation, Bellaire, TX, USA.
  • McDonald C; Texas Centers for Infectious Disease Associates, Fort Worth, TX, USA.
  • Ruane P; Ruane Clinical Research Group, Los Angeles, CA, USA.
  • Sanchez WE; Floridian Clinical Research, Miami Lakes, FL, USA.
  • Scribner A; Diagnostic Clinic of Longview Center for Clinical Research, Longview, TX, USA.
  • Liu SY; Gilead Sciences, Foster City, CA, USA.
  • VanderVeen LA; Gilead Sciences, Foster City, CA, USA.
  • Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.
  • Rhee MS; Gilead Sciences, Foster City, CA, USA.
  • Baeten JM; Gilead Sciences, Foster City, CA, USA.
  • Koenig E; Instituto Dominicano de Estudios Virológicos, Santo Domingo, Dominican Republic.
Lancet HIV ; 10(1): e15-e23, 2023 01.
Article em En | MEDLINE | ID: mdl-36566079

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article